Dec 10,2021

HypnoVR raises €4.5M in Series A

French digital therapeutics firm HypnoVR has raised €4.5 million in Series A funding for its virtual reality-based medical hypnosis solution for pain and anxiety. The round was led by Theodorus, the Banque des Territoires operating for the French state as part of the Investments for the Future Programme, Akiles and Capital Grand Est via Alsace Création. HypnoVR will use the funds to accelerate its international roll-out and extend the scope of application of its solution.

FUNDING SERIES A

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Feb 01,2022

Jasper Health Raises $25 Million in Series A Funding to Increase Access to Comprehensive Cancer Experience and Care Navigation Platform

Jasper Health, a first-of-its-kind cancer care navigation and experience platform, today announced a $25 million Series A funding round led by General Catalyst. The round, which was joined by new and existing investors Human Capital, W Health Ventures, Redesign Health, and 7wireVentures, brings Jasper Health’s total funding to approximately $31 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 09,2022

Oncological digital therapeutics company Fosanis raises more than $10.5M

Fosanis announced today that it closed a Series A funding round worth more than $10.5 million (€10 million). Berlin, Germany-based Fosanis, which develops prescription digital therapeutics for all oncological indications, picked up investments from existing shareholder Ananada Impact Ventures, as well as new investors Debiopharm Innovation Fund, Ship2B Ventures and Equity Pitcher.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 19,2022

OncoRes Medical raises another $12.5M

OncoRes Medical announced that it raised $12.5 million for its handheld imaging device for identifying cancer cells. Perth, Western Australia-based OncoRes designed its imaging system to facilitate real-time tumor assessment, helping surgeons more accurately identify and remove cancerous tissue, including for breast cancer.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 03,2022

Massive Bio Raises $9 Million To Scale Growth and Fuel Global Expansion of AI-Enabled Oncology Clinical Trial Platform

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient-centric clinical trial enrollment, raised $9 million co-led by Revo Capital and Kenan Turnacıoğlu, with additional participation from DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH, the German Development Finance Institution. This investment will enable the company to further scale its operations globally, invest in marketing, and launch additional non-status quo products in oncology clinical trial enrollment with its data-rich platform.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 04,2022

Atropos Health Announces $14M Series A, Taps Co-founder as CEO

Hyde served as a healthcare partner at the AI venture fund Symphony AI, where he led the investment in, co-founded, and operated Concert AI, an oncology RWD company – most recently valued at $1.9B. "I am excited about the enormous potential Atropos has to advance

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 26,2021

Engine Biosciences expands its digital drug discovery pipeline with $43M round

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former, a Singaporean outfit with an expert founding crew and a different approach to the business of finding new therapeutics, and it just raised $43 million in Series A round to keep growing. The $43 million round was led by Polaris Partners, with participation by newcomers Invus and a long list of existing investors.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 07,2020

Owkin raises $25 million as it builds a secure network for healthcare analysis and research

Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data. That’s the dream of the new New York-based startup Owkin, which has raised $25 million in fresh financing from investors in Series A round, including Bpifrance Large Venture, Cathay Innovation and MACSF (the French Pension Fund for Clinicians), alongside previous investors GV, F-Prime Capital and Eight Roads.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 28,2020

Sidekick Health scores $20M for its gamified digital care platform

Nordic digital therapeutics company, Sidekick Health, has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners. Existing investors, Novator and Frumtak Ventures, also participated in the oversubscribed round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 27,2019

Healthtech Startup Onco.com Secured $7 million In Series A Funding Round

Healthtech startup Onco.com has raised $7 million in its Series A funding round, which saw participation from Accel Partners, Chiratae Venture (earlier known as IDG Ventures) and Dream Incubator. The Bengaluru-headquartered startup is an online healthcare aggregator with focus on cancer care.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A